Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(7):550-556; doi:10.1093/jnci/92.7.550
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Diab, S. G.
Right arrow Articles by Clark, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diab, S. G.
Right arrow Articles by Clark, G. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 7, 550-556, April 5, 2000
© 2000 Oxford University Press

Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

Sami G. Diab, Richard M. Elledge, Gary M. Clark

Affiliations of authors: S. G. Diab, Rocky Mountain Cancer Centers—Aurora, CO; R. M. Elledge, G. M. Clark, Breast Center at Baylor College of Medicine, Houston, TX.

Correspondence to: Sami G. Diab, M.D., Rocky Mountain Cancer Centers—Aurora, 1700 S. Potomac St., Aurora, CO 80012 (e-mail: sami.diab{at} usoncology.com).

Background: The number of elderly patients with breast cancer is increasing. Limited age-related information available about this disease prompted this study. Patients and Methods: The study population was derived from 50828 and 256287 patients with invasive breast cancer in San Antonio breast cancer databases and the Surveillance, Epidemiology, and End Results (SEER) registry, respectively. Tumor biologic and clinical characteristics, local and systemic therapies, and survival according to the patient's age were analyzed. Survival was also compared with that of age-matched women from the general population. Results: In patients 55 years old or older, there was an association between increasing age at diagnosis and the presence of more favorable biologic characteristics of the tumor, including more tumors that express steroid receptors, lower proliferative rates, diploidy, normal p53, and absence of the expression of epidermal growth factor receptor and c-erbB2. In older patients with lymph node-negative disease and/or small tumors, the observed and expected survivals were almost identical. In the SEER registry, the 8-year survival of lymph node-negative patients relative to the expected survival of age-matched women from the general population was 1.01 (95% confidence interval [CI] = 0.98–1.04) for patients 70–74 years old, 1.06 (95% CI = 1.01–1.11) for patients 75–79 years old, and 1.09 (95% CI = 0.98–1.20) for patients 80–84 years old. Conclusion: In women 55 years old or older, advancing age is associated with more favorable tumor biology, and breast cancer survival in older women is similar to survival in the general population irrespective of disease status. This favorable outcome should be considered when making clinical decisions in older patients.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
S. Mook, M. K. Schmidt, B. Weigelt, B. Kreike, I. Eekhout, M. J. van de Vijver, A. M. Glas, A. Floore, E. J. T. Rutgers, and L. J. van 't Veer
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
Ann. Onc., October 13, 2009; (2009) mdp388v1.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
A. Hurria, F. L. Wong, S. Pal, C. T. Chung, S. Bhatia, J. Mortimer, G. Somlo, S. Hurvitz, D. Villaluna, and A. Naeim
Perspectives and Attitudes on the Use of Adjuvant Chemotherapy and Trastuzumab in Older Adults with HER-2+ Breast Cancer: A Survey of Oncologists
Oncologist, September 1, 2009; 14(9): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. Wildiers, B. Van Calster, L. V. van de Poll-Franse, W. Hendrickx, J. Roislien, A. Smeets, R. Paridaens, K. Deraedt, K. Leunen, C. Weltens, et al.
Relationship Between Age and Axillary Lymph Node Involvement in Women With Breast Cancer
J. Clin. Oncol., June 20, 2009; 27(18): 2931 - 2937.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. A. Schonberg, R. A. Silliman, and E. R. Marcantonio
Weighing the Benefits and Burdens of Mammography Screening Among Women Age 80 Years or Older
J. Clin. Oncol., April 10, 2009; 27(11): 1774 - 1780.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. A. Schonberg and E. P. McCarthy
Mammography Screening Among Women Age 80 Years and Older: Consider the Risks
J. Clin. Oncol., February 1, 2009; 27(4): 640 - 641.
[Full Text] [PDF]


Home page
JCOHome page
B. D. Badgwell, S. H. Giordano, Z. Z. Duan, S. Fang, I. Bedrosian, H. M. Kuerer, S. E. Singletary, K. K. Hunt, G. N. Hortobagyi, and G. Babiera
Mammography Before Diagnosis Among Women Age 80 Years and Older With Breast Cancer
J. Clin. Oncol., May 20, 2008; 26(15): 2482 - 2488.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. B. Muss, D. Tu, J. N. Ingle, S. Martino, N. J. Robert, J. L. Pater, T. J. Whelan, M. J. Palmer, M. J. Piccart, L. E. Shepherd, et al.
Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17
J. Clin. Oncol., April 20, 2008; 26(12): 1956 - 1964.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S Tozlu-Kara, V Roux, C Andrieu, J Vendrell, S Vacher, V Lazar, F Spyratos, M Tubiana-Hulin, P Cohen, P Dessen, et al.
Oligonucleotide microarray analysis of estrogen receptor {alpha}-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen
J. Mol. Endocrinol., October 1, 2007; 39(4): 305 - 318.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Crivellari, M. Aapro, R. Leonard, G. von Minckwitz, E. Brain, A. Goldhirsch, A. Veronesi, and H. Muss
Breast Cancer in the Elderly
J. Clin. Oncol., May 10, 2007; 25(14): 1882 - 1890.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. D. Smith, B. G. Haffty, A. Hurria, D. H. Galusha, and C. P. Gross
Postmastectomy Radiation and Survival in Older Women With Breast Cancer
J. Clin. Oncol., October 20, 2006; 24(30): 4901 - 4907.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. B. Elkin, A. Hurria, N. Mitra, D. Schrag, and K. S. Panageas
Adjuvant Chemotherapy and Survival in Older Women With Hormone Receptor-Negative Breast Cancer: Assessing Outcome in a Population-Based, Observational Cohort
J. Clin. Oncol., June 20, 2006; 24(18): 2757 - 2764.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
International Breast Cancer Study Group
Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93
J. Clin. Oncol., January 20, 2006; 24(3): 337 - 344.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. Brunello, U. Basso, C. Pogliani, A. Jirillo, C. Ghiotto, H. Koussis, F. Lumachi, M. Iacobone, L. Vamvakas, and S. Monfardini
Adjuvant chemotherapy for elderly patients (>=70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients
Ann. Onc., August 1, 2005; 16(8): 1276 - 1282.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Bajetta, G. Procopio, L. Celio, L. Gattinoni, S. Della Torre, L. Mariani, L. Catena, R. Ricotta, R. Longarini, N. Zilembo, et al.
Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women
J. Clin. Oncol., April 1, 2005; 23(10): 2155 - 2161.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. H. Giordano, G. N. Hortobagyi, S.-W. C. Kau, R. L. Theriault, and M. L. Bondy
Breast Cancer Treatment Guidelines in Older Women
J. Clin. Oncol., February 1, 2005; 23(4): 783 - 791.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. Sweeney, C. K. Blair, K. E. Anderson, D. Lazovich, and A. R. Folsom
Risk Factors for Breast Cancer in Elderly Women
Am. J. Epidemiol., November 1, 2004; 160(9): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
I. E. Smith and G. M. Ross
Breast Radiotherapy after Lumpectomy -- No Longer Always Necessary
N. Engl. J. Med., September 2, 2004; 351(10): 1021 - 1023.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. Schairer, P. J. Mink, L. Carroll, and S. S. Devesa
Probabilities of Death From Breast Cancer and Other Causes Among Female Breast Cancer Patients
J Natl Cancer Inst, September 1, 2004; 96(17): 1311 - 1321.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Crivellari, K. Price, R. D. Gelber, M. Castiglione-Gertsch, C.-M. Rudenstam, J. Lindtner, M. F. Fey, H.-J. Senn, A. S. Coates, J. Collins, et al.
Adjuvant Endocrine Therapy Compared With No Systemic Therapy for Elderly Women With Early Breast Cancer: 21-Year Results of International Breast Cancer Study Group Trial IV
J. Clin. Oncol., December 15, 2003; 21(24): 4517 - 4523.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. Kerlikowske, D. L. Miglioretti, R. Ballard-Barbash, D. L. Weaver, D. S.M. Buist, W. E. Barlow, G. Cutter, B. M. Geller, B. Yankaskas, S. H. Taplin, et al.
Prognostic Characteristics of Breast Cancer Among Postmenopausal Hormone Users in a Screened Population
J. Clin. Oncol., December 1, 2003; 21(23): 4314 - 4321.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Bouchardy, E. Rapiti, G. Fioretta, P. Laissue, I. Neyroud-Caspar, P. Schafer, J. Kurtz, A.-P. Sappino, and G. Vlastos
Undertreatment Strongly Decreases Prognosis of Breast Cancer in Elderly Women
J. Clin. Oncol., October 1, 2003; 21(19): 3580 - 3587.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
K. Monson, D. A. Litvak, and R. J. Bold
Surgery in the Aged Population: Surgical Oncology
Arch Surg, October 1, 2003; 138(10): 1061 - 1067.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
C. E. Holmes and H. B. Muss
Diagnosis and Treatment of Breast Cancer in the Elderly
CA Cancer J Clin, July 1, 2003; 53(4): 227 - 244.
[Abstract] [Full Text]


Home page
JCOHome page
W. F. Anderson, K. C. Chu, and S. Chang
Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities?
J. Clin. Oncol., June 15, 2003; 21(12): 2254 - 2259.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
H. B. Muss
Factors Used to Select Adjuvant Therapy of Breast Cancer in the United States: an Overview of Age, Race, and Socioeconomic Status
J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 52 - 55.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
M. Morrow and H. Krontiras
Who Should Not Receive Chemotherapy? Data From American Databases and Trials
J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 109 - 113.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Mirchandani and F. Muggia
Re: Prognosis and Treatment of Patients With Breast Tumors of One Centimeter or Less and Negative Axillary Lymph Nodes
J Natl Cancer Inst, September 19, 2001; 93(18): 1420a - 1421a.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Basche and T. Byers
Re: Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
J Natl Cancer Inst, January 3, 2001; 93(1): 64 - 65.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
N. S. Weiss
Re: Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
J Natl Cancer Inst, January 3, 2001; 93(1): 65 - 65.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. G. Diab, R. M. Elledge, and G. M. Clark
RESPONSE: Re: Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
J Natl Cancer Inst, January 3, 2001; 93(1): 65a - 66a.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.